- Home
- NOV vs PCVX Comparison
NOV vs PCVX Comparison
Compare NOV & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOV
- PCVX
- Stock Information
- Founded
- NOV 1862
- PCVX 2013
- Country
- NOV United States
- PCVX United States
- Employees
- NOV N/A
- PCVX N/A
- Industry
- NOV Metal Fabrications
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- NOV Industrials
- PCVX Health Care
- Exchange
- NOV Nasdaq
- PCVX Nasdaq
- Market Cap
- NOV 4.7B
- PCVX 4.0B
- IPO Year
- NOV 1996
- PCVX 2020
- Fundamental
- Price
- NOV $13.11
- PCVX $42.45
- Analyst Decision
- NOV Hold
- PCVX Strong Buy
- Analyst Count
- NOV 15
- PCVX 8
- Target Price
- NOV $15.93
- PCVX $114.17
- AVG Volume (30 Days)
- NOV 3.4M
- PCVX 1.9M
- Earning Date
- NOV 10-27-2025
- PCVX 11-05-2025
- Dividend Yield
- NOV 2.29%
- PCVX N/A
- EPS Growth
- NOV N/A
- PCVX N/A
- EPS
- NOV 1.21
- PCVX N/A
- Revenue
- NOV $8,790,000,000.00
- PCVX N/A
- Revenue This Year
- NOV N/A
- PCVX N/A
- Revenue Next Year
- NOV $0.16
- PCVX N/A
- P/E Ratio
- NOV $10.77
- PCVX N/A
- Revenue Growth
- NOV N/A
- PCVX N/A
- 52 Week Low
- NOV $10.84
- PCVX $27.66
- 52 Week High
- NOV $16.86
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- NOV 51.60
- PCVX 62.99
- Support Level
- NOV $12.50
- PCVX $42.00
- Resistance Level
- NOV $12.92
- PCVX $45.12
- Average True Range (ATR)
- NOV 0.40
- PCVX 2.01
- MACD
- NOV -0.05
- PCVX -0.05
- Stochastic Oscillator
- NOV 50.00
- PCVX 62.78
About NOV NOV Inc.
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.